Depending on the states of cancers, TGFβ/SMAD3 signaling can act as an oncogenic factor promoting the tumor cell invasion and metastasis in advanced cancers or functions as a regulator to inhibit cell proliferation and induce apoptosis in early-phase tumors. Here, TGFB1 is linked to neoplasm.